These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32458510)

  • 61. Invasive mould infections in the ICU setting: complexities and solutions.
    Bassetti M; Bouza E
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Emergence of the Molds Other than Aspergillus in Immunocompromised Patients.
    Arif S; Perfect JR
    Clin Chest Med; 2017 Sep; 38(3):555-573. PubMed ID: 28797495
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fusarium brain abscess: case report and literature review.
    Garcia RR; Min Z; Narasimhan S; Bhanot N
    Mycoses; 2015 Jan; 58(1):22-6. PubMed ID: 25476184
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
    Salavert-Lletí M; Zaragoza-Crespo R
    Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?
    Balajee SA; Borman AM; Brandt ME; Cano J; Cuenca-Estrella M; Dannaoui E; Guarro J; Haase G; Kibbler CC; Meyer W; O'Donnell K; Petti CA; Rodriguez-Tudela JL; Sutton D; Velegraki A; Wickes BL
    J Clin Microbiol; 2009 Apr; 47(4):877-84. PubMed ID: 19073865
    [No Abstract]   [Full Text] [Related]  

  • 66. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-
    Puerta-Alcalde P; Garcia-Vidal C
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36261156
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Disseminated fusariosis in a patient with acute lymphoblastic leukaemia].
    Hermansen NE; Ralfkiaer EM; Kjeldsen L
    Ugeskr Laeger; 2008 Sep; 170(37):2892. PubMed ID: 18796288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Incidence of non-candidal fungal infections in severe burn injury: an Australian perspective.
    Katz T; Wasiak J; Cleland H; Padiglione A
    Burns; 2014 Aug; 40(5):881-6. PubMed ID: 24380706
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Invasive mould sinusitis in patients with haematological malignancies: a 10 year single-centre study.
    Davoudi S; Kumar VA; Jiang Y; Kupferman M; Kontoyiannis DP
    J Antimicrob Chemother; 2015 Oct; 70(10):2899-905. PubMed ID: 26188039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.
    Teh BW; Chui W; Handunnetti S; Tam C; Worth LJ; Thursky KA; Slavin MA
    Leuk Lymphoma; 2019 Jun; 60(6):1572-1575. PubMed ID: 30632838
    [No Abstract]   [Full Text] [Related]  

  • 72. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus.
    Trief D; Gray ST; Jakobiec FA; Durand ML; Fay A; Freitag SK; Lee NG; Lefebvre DR; Holbrook E; Bleier B; Sadow P; Rashid A; Chhabra N; Yoon MK
    Br J Ophthalmol; 2016 Feb; 100(2):184-8. PubMed ID: 26112869
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Invasive mold infections in the university clinics of Leipzig in the period from 1992-1994].
    Nenoff P; Horn LC; Schwenke H; Mierzwa M; Rieske K; Haustein UF
    Mycoses; 1996; 39 Suppl 1():107-12. PubMed ID: 8767281
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
    Erjavec Z; Kluin-Nelemans H; Verweij PE
    Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use.
    Asawa P; Chahine Z; Vusqa U; Samhouri Y; Fazal S
    J Oncol Pharm Pract; 2022 Oct; 28(7):1654-1658. PubMed ID: 35253502
    [No Abstract]   [Full Text] [Related]  

  • 76. Current antifungal treatment of fusariosis.
    Al-Hatmi AMS; Bonifaz A; Ranque S; Sybren de Hoog G; Verweij PE; Meis JF
    Int J Antimicrob Agents; 2018 Mar; 51(3):326-332. PubMed ID: 28705676
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy.
    Eichenberger EM; Saullo J; Brander D; Wang SH; Perfect JR; Messina JA
    Med Mycol Case Rep; 2020 Mar; 27():17-21. PubMed ID: 31879587
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
    Prajna NV; Prajna L; O'Brien KS; Sun CQ; Acharya N; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2015 Oct; 133(10):1210-1. PubMed ID: 26110254
    [No Abstract]   [Full Text] [Related]  

  • 79. Impact of fungal species cultured on outcome in horses with fungal keratitis.
    Sherman AB; Clode AB; Gilger BC
    Vet Ophthalmol; 2017 Mar; 20(2):140-146. PubMed ID: 27061354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib.
    Holowka T; Cheung H; Malinis M; Gan G; Deng Y; Perreault S; Isufi I; Azar MM
    J Infect Chemother; 2021 Dec; 27(12):1700-1705. PubMed ID: 34389223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.